Twist Bioscience Corp Deferred Tax Assets, Net of Valuation Allowance
Financial Statements › Balance Sheet › Assets › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-11-17
- 2025-09-30: Deferred Tax Assets, Net of Valuation Allowance $15.41M.
- 2024-09-30: Deferred Tax Assets, Net of Valuation Allowance $18.25M.
- 2023-09-30: Deferred Tax Assets, Net of Valuation Allowance $31.90M.
- 2022-09-30: Deferred Tax Assets, Net of Valuation Allowance $33.58M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2025-09-30 | $15.41M 10-K · filed 2025-11-17 |
| 2024-09-30 | $18.25M 10-K · filed 2025-11-17 |
| 2023-09-30 | $31.90M 10-K · filed 2024-11-18 |
| 2022-09-30 | $33.58M 10-K · filed 2023-11-21 |
| 2021-09-30 | $20.04M 10-K/A · filed 2023-06-05 |
| 2020-09-30 | $7.65M 10-K · filed 2021-11-23 |
| 2019-09-30 | $127.00K 10-K · filed 2020-11-27 |
| 2018-09-30 | $183.00K 10-K · filed 2019-12-13 |